MM Group account plan
Innovative recyclable packaging products
At a glance
MM Group (Mayr-Melnhof Karton) makes cartonboard, paper and folding cartons in 23 countries: EUR 3,885.3 million 2025 sales, 13,347 employees.
MM Group (Mayr-Melnhof Karton AG, listed in Vienna) produces cartonboard, folding cartons, kraft and fine papers, leaflets and labels for consumer goods and pharma customers, integrated from fibres to boxes. In 2025 it had 60 locations in 23 countries, around 3,500 customers and sales in more than 130 countries, with 78 % of sales going to Europe. 2025 sales were EUR 3,885.3 million (- 4.8 %), adjusted EBITDA EUR 418.2 million and profit for the year EUR 77.0 million, with 13,347 employees. About 60 % of the shares are held by the core shareholder families in a syndicate. In November 2026 it agreed to sell 70 % of its Packaging operations to KPS Capital Partners and refocus on Board & Paper.
Business units
MM Food & Premium Packaging
40 % of Group sales; EUR 1,538.4 million in 2025Folding cartons for food and for premium and speciality goods (home care, personal care, beauty, cigarette, luxury, e-commerce, electronics), around 88 % sold to multinational groups on multi-year agreements; 29 plants and 5,742 employees. The TANN tipping-paper business was sold in June 2025, and the Romanian expansion started commercial production. Led by Roman Billiani; to be sold to KPS (70 %) with completion expected in the first half of 2027.
MM Pharma & Healthcare Packaging
16 % of Group sales; EUR 618.3 million in 2025Secondary pharma packaging (folding cartons, leaflets, labels) for large pharma companies and CMOs in Europe and North America, from 24 plants in 9 countries. Adjusted operating profit rose 24.9 % in 2025 and kept growing in 2026 on GLP-1 demand, while low-margin business is deliberately withdrawn. Led by Andreas Koppitz; part of the KPS transaction perimeter.
MM Board & Paper
44 % of Group sales; EUR 1,930.2 million in 2025Recycled and virgin fibre cartonboard, coated liner, fine and kraft papers and NSBK pulp from seven production locations, with 90 % of sales in Europe and more than 1,800 customers. Margins are under pressure from overcapacity, imports and energy costs, with an adjusted operating profit of EUR - 43.6 million in Q1-3 2026. Led by Alexander Loimayr; it will become the group's core business after the Packaging sale.
Strategic priorities
- Fit-For-Future earnings programme
- The programme delivered around EUR 70 million in 2025 and EUR 105 million in H1 2026; the target was raised to more than EUR 330 million P&L benefit by 2027 versus 2024 (excl. TANN).
- Separation of Packaging and Board & Paper
- Sale of 70 % of the Packaging operations to KPS Capital Partners at an enterprise value of EUR 2.4 billion, so each business can pursue its own strategy, with completion expected in the first half of 2027.
- Board & Paper as an independent supplier
- After the deal MM Group will focus on cartonboard as an independent supplier to the packaging industry, backed by a long-term supply agreement with MM Packaging and the planned Arnsberg mill acquisition.
- Balance sheet and shareholder returns
- Proceeds will repay about EUR 1 billion of debt and fund a special distribution of EUR 0.5 to 0.6 billion; targets are net debt/adjusted EBITDA 1.5-2.5x and a 40-60 % dividend payout.
- Growth in pharma packaging
- Named growth areas are GLP-1, oncology, medical devices, eye care, anti-counterfeiting and smart packaging, with a targeted investment programme for the US sites.
Latest results
For the first three quarters of 2026 sales were EUR 2,774.7 million against EUR 2,890.8 million pro forma excl. TANN, adjusted EBITDA fell to EUR 259.1 million (margin 9.3 % vs 10.3 %) and adjusted operating profit to EUR 93.0 million. Both packaging divisions beat the prior year: Food & Premium adjusted operating profit rose 5.1 % and Pharma & Healthcare 22.4 %. Board & Paper posted adjusted EBITDA of EUR - 18.1 million in Q3, hit by pricing pressure, higher energy, transport and chemicals costs and standstills at MM Kwidzyn and MM Kotkamills. Management says "Demand in Packaging is picking up", while overcapacity still prevents full pass-through of energy costs in Board & Paper.
Investments and deals
- Sale of Packaging majority to KPS
- Enterprise value EUR 2.4 billion, about 9x 2026E adjusted EBITDA; MM invests approximately EUR 0.4 billion for its 30 % stake and expects net cash proceeds of approximately EUR 1.8 to 1.9 billion.
- Kwidzyn modernisation
- A new continuous digester, rewinder and sheeter at MM Kwidzyn, about EUR 100 million in aggregate, due in autumn 2026 and expected to add around EUR 30 million operating profit a year from 2027.
- Arnsberg cartonboard mill acquisition
- In mid-August 2026 MM Board & Paper agreed to acquire the operating business of the R.D.M. Arnsberg recycled cartonboard mill in Germany, specialised in liner.
- Capex programme
- Capex was EUR 232.7 million in 2025 and is expected at around EUR 250 million in 2026; investments in Kwidzyn, Romania and the US are reported on track and within budget.
- Portfolio clean-up
- Sale of TANN Group (proceeds EUR 343.3 million), Bangor and Leeuwarden, closure of Karaman, and site optimisation in France and Spain to be completed in 2026.
Challenges and risks
- Cartonboard overcapacity
- 2025 was the third consecutive year of a prolonged market downturn, with structural overcapacity, new European virgin fibre capacity and rising Asian imports pressing prices.
- Energy and input costs
- Board & Paper relies largely on natural gas, CO2 free allocations will shrink, and the Middle East conflict raised energy, transportation and chemicals costs in 2026.
- Weak European consumer demand
- Subdued European consumption reduced folding carton volumes, with Food & Premium volumes down 5.9 % excl. TANN in Q1-3 2026.
- Tariffs and regulation
- US tariffs weighed on European pharma packaging exports to the US; listed risks include EUDR, tobacco regulation TPD3 and EU pharma legislation.
- Concentration on the cyclical board business
- After the sale MM keeps the cyclical cartonboard division, which the CEO described as being in a crisis; its retained 30 % stake can fall to 20 % if 2027 EBITDA targets are missed.
What leadership says
“As the European leader in folding cartonboard, our Board & Paper business will become an independent supplier to the packaging industry.”
“It is better to have 30% of a growing, successful business than 100% of a business we no longer have the means to really develop.”
“The divestment of TANN was a consistent step that strengthens our balance sheet and provides additional operational clarity.”
Where a supplier can help
- Energy cost and decarbonisation in the mills
- Tied to the energy-cost challenge in Board & Paper: biomass, photovoltaics, energy efficiency and CO2 management for gas-dependent mills.
- Carve-out and separation services
- Tied to the KPS transaction: IT separation, finance, legal and HR support for splitting Packaging from Board & Paper before completion in the first half of 2027, and rebranding of the parent.
- Cost and procurement savings
- Tied to the Fit-For-Future target of more than EUR 330 million: procurement, operations and SG&A efficiency tools.
- Mill integration and modernisation
- Tied to the Arnsberg acquisition and the Kwidzyn projects: equipment, maintenance and turnaround services for cartonboard and pulp lines.
- Smart and pharma packaging technology
- Tied to the pharma growth areas: RFID/NFC, anti-counterfeiting and capacity for US sites serving GLP-1 customers.
Tamtam's reading of the priorities and challenges above, not the company's own words.
Selling to companies like MM Group?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companiesKey documents
Read in full by Tamtam; each summary links to the document itself.
- MM Annual Report 2025 (Mayr-Melnhof Karton AG)
- MM Group (Mayr-Melnhof Karton AG, Vienna) is a fibre-based consumer packaging group run in three divisions: MM Food & Premium Packaging (40 % of Group sales), MM Pharma & Healthcare Packaging (16 %) and MM Board & Paper (44 %); 60 locations in 23 countries, 13,347 employees, ~3,500 customers, 78 % of sales in Europe.
- FY2025: consolidated sales EUR 3,885.3 million (- 4.8 %, mainly the sale of TANN Group in June 2025); adjusted EBITDA EUR 418.2 million (margin 10.8 %); adjusted operating profit EUR 195.4 million (+ 2.8 %, pro forma excl. TANN + 15.0 %); profit for the year EUR 77.0 million (- 30.3 %) on a 47.2 % effective tax rate.
- One-off effects: EUR 125.1 million gain on the TANN sale, EUR 70.5 million impairment at MM Kolicevo (Board & Paper), EUR 29.0 million Fit-For-Future restructuring (incl. Pharma footprint optimisation in France and Spain).
- The Group-wide Fit-For-Future programme contributed around EUR 70 million in 2025; management expects an earnings uplift of more than EUR 250 million by 2027 versus 2024 (excl. TANN and market effects), up from > EUR 150 million at launch.
- Board & Paper stays the weak spot: adjusted operating margin 0.2 % (2024: - 1.0 %) amid structural overcapacity in European virgin fibre cartonboard, US export volumes returning to Europe and Asian imports; Pharma & Healthcare adjusted operating profit + 24.9 % on GLP-1 growth in the US.
- Balance sheet: net debt cut to EUR 913.7 million (2.2x adjusted EBITDA, 43 % of equity); equity ratio 47.0 %; 569,019 shares bought back for approx. EUR 41.2 million; new dividend policy pays 40-60 % of profit, EUR 2.00/share proposed (+ 11 %).
- 2026 outlook: no market improvement foreseeable; capex around EUR 250 million; maintenance standstills ~EUR 40 million in Q3/Q4; two Middle East packaging plants (~2 % of sales, ~6 % of adjusted EBITDA) face business interruptions.
- Decarbonisation: Scope 1+2 emissions - 11 % in 2025 (- 59 % vs 2019); new continuous pulp digester at MM Kwidzyn (end 2026) to cut the mill's CO2 by about a third; two electric boilers at Kotkamills planned for spring 2027.
- MM Half-Year Report 2026
- H1 2026 sales EUR 1,849.3 million (- 8.9 % reported; - 4.7 % pro forma excl. TANN), driven by lower Board & Paper prices and lower Food & Premium volumes.
- Adjusted EBITDA EUR 200.2 million (pro forma excl. TANN - 3.5 %; margin 10.8 %), up from EUR 187.7 million in H2 2025; adjusted operating profit EUR 89.8 million; profit for the period EUR 31.2 million (H1 2025: EUR 164.3 million, which included the TANN gain); EPS EUR 1.60.
- Fit-For-Future delivered EUR 105 million in H1 and > EUR 100 million is expected in H2; the 2027 target was raised to more than EUR 330 million versus 2024 (from > EUR 250 million).
- Pharma & Healthcare Packaging adjusted EBITDA + 13.7 % to EUR 45.6 million (margin 14.3 %) on GLP-1 demand, North America and Ireland; Food & Premium excl. TANN adjusted EBITDA EUR 97.9 million (+ 0.9 %, margin 14.3 %).
- Board & Paper adjusted EBITDA EUR 56.8 million (- 19.3 %, margin 6.0 %); capacity utilisation 87 %; key Kwidzyn projects (~EUR 100 million capex) due in autumn 2026, worth ~EUR 30 million annual operating profit from 2027.
- Net debt EUR 945.2 million (2.4x adjusted EBITDA), equity ratio 46.9 %; free cash flow EUR 37.0 million; capex EUR 111.8 million.
- Agreement signed mid-August to acquire the operating business of R.D.M. Arnsberg recycled cartonboard mill (Germany); Romanian packaging expansion started commercial production in October.
- H2 outlook: subdued demand, higher transport, energy, chemical, wood and paper-for-recycling costs; Q3 standstills at Kwidzyn and Kotkamills to cost about EUR 35 million of operating profit.
- MM Trading Statement for the first three quarters of 2026
- Q1-3 2026 sales EUR 2,774.7 million (- 6.9 % reported; - 4.0 % pro forma excl. TANN); adjusted EBITDA EUR 259.1 million (pro forma - 12.9 %, margin 9.3 %); adjusted operating profit EUR 93.0 million (pro forma - 28.0 %).
- Q3 alone was weak: adjusted EBITDA EUR 58.9 million and adjusted operating profit EUR 3.2 million on sales of EUR 925.4 million.
- Food & Premium Packaging excl. TANN: adjusted EBITDA + 1.5 % to EUR 152.2 million (margin 14.5 %), helped by a good Q3 and fixed-cost cuts.
- Pharma & Healthcare Packaging: adjusted EBITDA + 12.7 % to EUR 68.2 million (margin 14.3 %); growth with key GLP-1 customers, low-margin business deliberately reduced.
- Board & Paper: adjusted EBITDA EUR 38.7 million (Q1-3 2025: EUR 86.9 million), adjusted operating profit EUR - 43.6 million; Q3 adjusted EBITDA EUR - 18.1 million after maintenance standstills (~EUR 36 million) and energy, chemicals and transport cost increases tied to the Middle East conflict; price increases implemented since October.
- Fit-For-Future one-offs around EUR 40 million; Arnsberg mill acquisition still planned.
- Outlook: packaging demand picking up, Pharma accelerating in GLP-1; Board & Paper overcapacity, reduced by a peer's exit, still blocks full pass-through of energy costs.
- MM Group to sell majority stake in its Packaging business to KPS Capital Partners and plans a special distribution to shareholders
- On 9 November 2026 MM Group signed a binding agreement to sell its Packaging business (Food & Premium Packaging excl. Iran and Tunisia, plus Pharma & Healthcare Packaging) to a new holding company of KPS Capital Partners; KPS will hold 70 %, MM Group 30 %.
- Enterprise value EUR 2.4 billion, an implied 2026E EV / adj. EBITDA multiple of approximately 9x.
- After reinvesting approximately EUR 0.4 billion for its 30 % stake, MM expects cash proceeds of approximately EUR 1.8 to 1.9 billion and net cash of approximately EUR 0.8 to 0.9 billion after completion.
- Planned special distribution to shareholders of EUR 0.5 to 0.6 billion after completion; proceeds also go to debt repayment and strategic opportunities.
- MM's stake can fall to a minimum of 20 % if certain FY2027 EBITDA targets are missed.
- MM Group will focus on Board & Paper as an independent supplier to the packaging industry, tied to the Packaging business by a long-term cartonboard supply agreement; the business keeps the MM Packaging name.
- Completion expected in the first half of 2027, subject to approvals and French works-council consultation; the stake will then be equity-accounted.
- Mayr-Melnhof verkauft Verpackungssparte in 2,4-Mrd.-Euro-Deal (Reuters, Oswald press briefing)
- At a press briefing in Vienna on 10 November 2026, CEO Peter Oswald called the sale of 70 % of the Packaging business to KPS "a very, very good solution, above all a smart solution" (translated).
- His rationale: MM alone lacks the capital to grow Packaging and keep up with much larger international competitors; "It is better to have 30% of a growing, successful business than 100% of a business we no longer have the means to really develop" (translated).
- The deal values the unit at EUR 2.4 billion (about nine times expected 2026 adjusted EBITDA); MM's shares rose by more than 22 % intraday to EUR 82.
- Proceeds of EUR 1.8-1.9 billion net of a ~EUR 400 million reinvestment repay about EUR 1 billion of financial debt, leaving net cash of EUR 800-900 million; a EUR 500-600 million special distribution is planned.
- Oswald says the cartonboard business is in crisis (high energy costs, price pressure) but expects improvement since competitors have closed mills, possibly in about a year; debt relief takes "the backpack" off the division (translated).
- He sees an IPO of the packaging company in five to seven years as the "ideal solution" for KPS's exit; the listed parent needs a new logo and possibly a new name.
- Mayr-Melnhof-Gruppe verkauft Verpackungsgeschäft (APA, Oswald press briefing)
- APA report on CEO Peter Oswald's Vienna press briefing (10 November 2026) about selling the Packaging business to KPS while keeping 30 %; the business keeps the MM Packaging name.
- Oswald admitted the deal is "not intuitive", "but if you think it through, it is a smart solution" (translated): Packaging is well set up for growth but the group lacks the capital for it.
- He says the packaging unit, with a good EUR 2 billion of annual sales (slightly more than half of group sales), was valued above the whole group's current stock-market value.
- Valuation EUR 2.4 billion; EUR 1.8-1.9 billion flows to MM; the retained 30 % is valued at only EUR 400 million because KPS adds debt to the new company; the stake can fall to 20 % if 2027 EBITDA targets are missed.
- About EUR 1 billion goes to debt reduction and EUR 500-600 million to shareholders after closing; nothing changes for employees.
- Extra benefit for cartonboard: other packaging makers will no longer see MM as a competitor, opening new business, Oswald says.
Questions about MM Group
What does MM Group do?
MM Group makes cartonboard, paper and pulp and turns them into folding cartons, leaflets and labels for consumer goods and pharma customers, from 60 locations in 23 countries.
What was MM Group's revenue in 2025?
Sales were EUR 3,885.3 million in 2025 (- 4.8 %), with adjusted EBITDA of EUR 418.2 million and profit for the year of EUR 77.0 million.
How many employees does MM Group have?
It had 13,347 employees in 2025 and 13,080 at mid-2026.
Who leads MM Group?
Peter Oswald chairs the Management Board and is CEO, with Franz Hiesinger as CFO; Wolfgang Eder chairs the Supervisory Board.
Why is MM Group selling its Packaging business?
MM agreed to sell 70 % of Packaging to KPS Capital Partners at an enterprise value of EUR 2.4 billion because it lacks the capital to fund that business's growth alone; it keeps 30 % and will focus on Board & Paper.
Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)